Increasing the release and regulation of neurotransmitters such as dopamine
These timelines represent a general pattern, not a guarantee
A phase 2b randomized, double-blind, placebo-controlled study is ongoing to look at the effect of 0.5, 1, and 2 mg of larazotide acetate in the treatment of patients with CD who have persistent symptoms despite being on a gluten-free diet (ClinicalTrials.gov Identifier: NCT01396213)
For preparation guidance, see our companion article: Cagrilintide Research Peptide Reconstitution Guide: Best Practices for Laboratory Solubility and Preparation
Results were expressed relative to individual well baseline and AUC was calculated
Men with low testosterone may notice that weight is harder to lose and easier to regain, even with diet and exercise changes